Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) insider Campbell Rogers sold 16,918 shares of the firm’s stock in a transaction on Thursday, March 19th. The stock was sold at an average price of $25.00, for a total value of $422,950.00. Following the completion of the sale, the insider directly owned 16,918 shares of the company’s stock, valued at $422,950. The trade was a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Campbell Rogers also recently made the following trade(s):
- On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total transaction of $668,756.57.
- On Friday, September 18th, Campbell Rogers sold 12,156 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $609,623.40.
- On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $563,963.23.
- On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total transaction of $1,122,081.32.
- On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total transaction of $1,316,554.33.
- On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The stock was sold at an average price of $50.15, for a total transaction of $987,052.30.
Heartflow Trading Down 2.7%
NASDAQ:HTFL opened at $44.63 on Friday. The company has a market capitalization of $3.92 billion, a P/E ratio of -48.51 and a beta of 2.50. The firm has a 50-day moving average price of $51.82 and a two-hundred day moving average price of $35.55. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $60.65.
Heartflow (NASDAQ:HTFL – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. The company had revenue of $72.86 million for the quarter. During the same quarter in the prior year, the firm earned ($0.27) earnings per share. On average, equities research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. XXEC Inc. bought a new stake in shares of Heartflow during the 2nd quarter valued at about $2,524,764,000. BlackRock Inc. bought a new stake in Heartflow in the 2nd quarter worth about $152,502,000. Bamco Inc. NY purchased a new position in shares of Heartflow in the second quarter worth approximately $94,625,000. Jupiter Topco LLC bought a new stake in Heartflow during the 2nd quarter worth approximately $70,983,000. Finally, Janus Henderson Group PLC lifted its holdings in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.
Heartflow News Roundup
Here’s some of the latest news about HTFL:
- Negative Sentiment: Filings reported two November 17 sales totaling 36,345 shares at an average of $46.39, alongside another sale of 12,157 shares on October 22 at $55.01. The disclosures also describe additional sales earlier in the year. Repeated insider selling can weigh on sentiment, though the sales were conducted under a pre-arranged plan. SEC Form 4 filing
Wall Street Analyst Weigh In
Several analysts have weighed in on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Heartflow in a report on Wednesday, November 4th. JPMorgan Chase & Co. lifted their target price on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Canaccord Genuity Group lifted their price objective on shares of Heartflow from $56.00 to $69.00 and gave the company a “buy” rating in a research report on Friday, November 13th. Wall Street Zen upgraded Heartflow from a “hold” rating to a “buy” rating in a research note on Sunday, November 15th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $64.00 price target (up from $45.00) on shares of Heartflow in a research report on Tuesday, October 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $60.12.
Get Our Latest Stock Report on Heartflow
About Heartflow
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Featured Articles
- Five stocks we like better than Heartflow
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
